Current dividend yield | 3.34 % |
Dividendenrendite 5 Jahre | 4.77 % |
Dividend Yield 10Y | 7.14 % |
Payout 3Y | 5.96 % |
The Grand Pharmaceutical stock dividend is paid once a year. In order to receive a dividend, you should generally own the Grand Pharmaceutical stock before the ex-dividend date. The Dividend Calendar shows that the ex-day date was last at April . The dividend from Grand Pharmaceutical was paid in April.
Year | Dividend | Ex-day & Payday |
Frequency | |
---|---|---|---|---|
Fiscal Year | Dividend per Share | Ex-Day | Payday | Payment frequency |
2024 |
HKD0.26
HKD0.26
|
Apr 14 2025
Apr 14 2025
Apr 28 2025
Apr 14 25
Apr 28 25 |
Apr 28 2025 |
annual
yearly
|
2023 |
HKD0.26
HKD0.26
|
Jun 06 2024
Jun 06 2024
Jun 27 2024
Jun 06 24
Jun 27 24 |
Jun 27 2024 |
annual
yearly
|
2022 |
HKD0.14
HKD0.14
|
Jun 09 2023
Jun 09 2023
Jun 27 2023
Jun 09 23
Jun 27 23 |
Jun 27 2023 |
annual
yearly
|
2021 |
HKD0.11
HKD0.11
|
Jun 06 2022
Jun 06 2022
Jun 21 2022
Jun 06 22
Jun 21 22 |
Jun 21 2022 |
annual
yearly
|
2020 |
HKD0.11
HKD0.11
|
Jun 08 2021
Jun 08 2021
Jun 23 2021
Jun 08 21
Jun 23 21 |
Jun 23 2021 |
annual
yearly
|
2019 |
HKD0.096
HKD0.1
|
Jun 26 2020
Jun 26 2020
Jul 17 2020
Jun 26 20
Jul 17 20 |
Jul 17 2020 |
annual
yearly
|
2018 |
HKD0.086
HKD0.09
|
Jun 12 2019
Jun 12 2019
Jun 28 2019
Jun 12 19
Jun 28 19 |
Jun 28 2019 |
annual
yearly
|
Grand Pharmaceutical paid a Dividend of HKD0.26 Per Share in the financial year 2024. With a stock price of HKD9.82 at Jun 12 2025, the current dividend yield is 2.65% (calculation: HKD0.26 / HKD9.82 = 2.65%). No special dividend was paid.
The average Grand Pharmaceutical dividend yield over the last 5 years is 3.39% and the average over the last 10 years is 2.59%.
The payout ratio of Grand Pharmaceutical in relation to the last financial year is 37.14%. The payout ratio smoothed over 3 years is 36.07%. The calculation is based on the sum of all dividend payments divided by the cumulative earnings per share(EPS).
Metric | Grand Pharmaceutical |
---|---|
Current dividend yield | 2.65% |
Dividend Yield 5Y | 3.39% |
Dividend Yield 10Y | 2.59% |
Payout 1Y | 37.14% |
Payout 3Y | 36.07% |
Grand Pharmaceutical has been paying a dividend for 7 years and has not lowered the dividend for 7 years (dividend continuity). As a result, the dividend was not increased recently.
The Dividend Growth in relation to the previous financial year amounts to 0.00%. The average Grand Pharmaceutical Dividend Growth over the last 5 years is 22.05%.
Metric | Grand Pharmaceutical |
---|---|
Increased | 0 Years |
Continuity | 7 Years |
Paid | 7 Years |
Growth 1Y | 0.00% |
Growth 5Y | 22.05% |
Grand Pharmaceutical has been paying a dividend for 7 years and has not lowered the dividend for 7 years (dividend continuity). As a result, the dividend was not increased recently.
The Dividend Growth in relation to the previous financial year amounts to 0.00%. The average Grand Pharmaceutical Dividend Growth over the last 5 years is 22.05%.
On the stock exchange, the Grand Pharmaceutical stock (ISIN: BMG210A71016) is not traded as a top scorer in June 2025 according to the dividend strategy.
The stock price of Grand Pharmaceutical 104.58% has risen since the beginning of the year 2025. However, the return generated in the past says nothing about the future return. You can find the Grand Pharmaceutical stock price in real time at the top of the page.
Grand Pharmaceutical (symbol: 512) is valued at a Price / Earnings Ratio (P/E ratio) of 14.03 and a price/sales ratio (P/S ratio) of 2.82 valued. Based on analyst estimates, the Grand Pharmaceutical stock forecast 2025 of the current financial year corresponds to a valuation of 16.37 according to P/E ratio and 2.64 according to P/S.
Metric | Grand Pharmaceutical |
---|---|
Dividend Score | ??/15 |
Performance 2025 |
104.58%
|
P/E TTM | 14.03 |
P/S TTM | 2.82 |
P/E forward | 16.37 |
P/S forward | 2.64 |
Grand Pharmaceutical (symbol: 512) is valued at a Price / Earnings Ratio (P/E ratio) of 14.03 and a price/sales ratio (P/S ratio) of 2.82 valued. Based on analyst estimates, the Grand Pharmaceutical stock forecast 2025 of the current financial year corresponds to a valuation of 16.37 according to P/E ratio and 2.64 according to P/S.
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.